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Background: Cancer cells exhibit increased glycolysis for ATP production (the Warburg effect) and macromolecular
biosynthesis; it is also linked with therapeutic resistance that is generally associated with compromised respiratory
metabolism. Molecular mechanisms underlying radio-resistance linked to elevated glycolysis remain incompletely
understood.
Methods: We stimulated glycolysis using mitochondrial respiratory modifiers (MRMs viz. di-nitro phenol, DNP;
Photosan-3, PS3; Methylene blue, MB) in established human cell lines (HEK293, BMG-1 and OCT-1). Glucose utilization
and lactate production, levels of glucose transporters and glycolytic enzymes were investigated as indices of glycolysis.
Clonogenic survival, DNA repair and cytogenetic damage were studied as parameters of radiation response.
Results: MRMs induced the glycolysis by enhancing the levels of two important regulators of glucose metabolism
GLUT-1 and HK-II and resulted in 2 fold increase in glucose consumption and lactate production. This increase in
glycolysis resulted in resistance against radiation-induced cell death (clonogenic survival) in different cell lines at
an absorbed dose of 5 Gy. Inhibition of glucose uptake and glycolysis (using fasentin, 2-deoxy-D-glucose and
3-bromopyruvate) in DNP treated cells failed to increase the clonogenic survival of irradiated cells, suggesting that
radio-resistance linked to inhibition of mitochondrial respiration is glycolysis dependent. Elevated glycolysis also
facilitated rejoining of radiation-induced DNA strand breaks by activating both non-homologous end joining (NHEJ)
and homologous recombination (HR) pathways of DNA double strand break repair leading to a reduction in
radiation-induced cytogenetic damage (micronuclei formation) in these cells.
Conclusions: These findings suggest that enhanced glycolysis generally observed in cancer cells may be
responsible for the radio-resistance, partly by enhancing the repair of DNA damage.
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Ionizing radiation plays an important role in the
management of a majority of malignancies [1], although
many tumors like glioma and several carcinomas are
known to be refractory to radiotherapy with marginal
benefits in survival. However, the molecular mechanisms
underlying this radio-resistance of cancer cells remain
poorly understood. One of the most common signatures
of highly malignant tumors is their capacity to
metabolize more glucose to lactic acid than normal tis-
sues, which confers a selective growth advantage [2].* Correspondence: dwarakanathdrbs@gmail.com
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unless otherwise stated.Cells derived from hypoxic tumors typically maintain
their metabolic phenotypes even under normoxic culture
conditions (Warburg effect), indicating that aerobic
glycolysis is constitutively upregulated through stable
genetic or epigenetic changes [2]. It is also reported that
mitochondrial defect linked stabilization of HIF1α in-
duces glycolytic phenotype in cancer cells and promotes
aggressiveness of tumors [2,3]. On the other hand, effi-
cient oxidative phosphorylation in cancer cells is re-
quired for execution of apoptosis through the generation
of reactive oxygen species (ROS) [4]. Therefore, meta-
bolically reprogrammed and highly glycolytic cancer
cells can easily escape the death processes, conferring
resistance to therapeutic modalities [5].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sis associated with tumors have been well exploited
for the diagnosis of the disease using fluoro-deoxy
glucose (FDG) based positron emission tomography
(PET) imaging and the efficacy of glycolytic inhibi-
tors as sensitizers to radiation and chemotherapeutic
drugs has established in pre-clinical studies, while
clinical trials are at different stages of evaluation
[6-9]. Considerable amount of evidences suggest that
inhibition of glycolysis leads to compromised DNA
repair, which is accompanied by the depletion of en-
ergy [ATP and AXP (AMP and ADP)] in cells with
high rates of glycolysis like the cancer cells, causing
death [10-14]. However, the mechanisms underlying
enhanced resistance to radiation-induced cell death
in cells with high endogenous rates of glycolysis, like the
cancer cells are not completely understood, although al-
terations in pH and lactate levels have been implicated
[2]. Therefore, present studies were undertaken to
examine if transient stimulation of glycolysis (before
irradiation) using MRMs is sufficient to confer radio-
resistance and also to unravel the underlying mechanisms.
Results obtained in human malignant and non-malignant
cell lines clearly show that stimulation of glycolysis
using MRMs reduces radiation-induced cell death by
enhancing the repair of DNA damage leading to a re-




Dulbecco’s Minimum Essential Medium (DMEM),
Penicillin G, Streptomycin, Nystatin, Dimethyl sulfoxide
(DMSO), Dichlorodihydrofluorescein diacetate (H2DCFH-
DA), Potassium chloride (KCl), Magnesium chloride
(MgCl2), Ethylene-di-amine-tetra acetate (EDTA),
Protease inhibitor cocktail, HEPES, Hoechst-33258 (H258),
propidium iodide (PI), RNAase, Di-nitrophenol and
methylene blue were procured from Sigma chemicals
Co. (St Louis, USA). Photosan (PS3) was procured
from See Lab, Germany. Bicinchoninic acid (BCA, Thermo
fisher scientific Rockford USA), primary and HRP conju-




The cerebral glioma cell line (BMG-1; diploid, wild type
p53) established by us earlier [12] whereas; OCT-1 (oral
carcinoma) and HEK293 (human embryonic kidney)
cells were obtained from NCCS, Pune, India. BMG-1
and OCT-1 cells were maintained as monolayers in
Dulbecco’s modified Eagles medium (DMEM) sup-
plemented with fetal bovine serum (5% for BMG-1and 10% for OCT-1), HEPES and antibiotics as de-
scribed earlier [12]. HEK293 was grown in high glucose
(4.5 g/L) DMEM supplemented with 10% fetal bovine
serum (FBS). All experiments were carried out in expo-
nentially growing cells.
Treatments
Cells were treated with MRMs at concentrations that
induce glycolysis without any cytotoxicity (data not
shown). The drug concentrations used in all the experi-
ments were 1 μM for DNP, 25 μg/ml for PS3 and 25 μM
for MB. Cells were exposed to 5 Gy γ-ray irradiation in
all experiments (unless specified otherwise in particular
experiments), using Bhabhatron-II, a teletherapy ma-
chine from Panacea, Medical Technologies Pvt. Ltd.
(Bangalore, India) at 80 cm SSD and 35x35 cm field with
a dose rate of 2 Gy/min.
Glucose consumption and lactate production assay
BMG-1, OCT-1 and HEK293 cells were incubated in
HBSS or HBSS containing MRMs before irradiation.
Cells were incubated for 4 hours; every hour HBSS sam-
ple was taken from dishes and frozen immediately for
further analysis. The amount of glucose remaining un-
used and the lactate produced were estimated in the
HBSS using enzymatic assays. Glucose was determined
by the glucose-oxidase method using Tecnicon RA-500
auto analyzer. Lactate was estimated using lactate oxi-
dase method based kit (Randox; Cat. No.-LC2389).
Glucose consumption and lactate production were esti-
mated at the end of every hour (up to four hours) and
presented as the average consumption or production per
hour. The number of viable cells was counted on
hemocytometer using trypan blue (0.4%) exclusion test
and glucose consumption or lactate production was nor-
malized with respect to the number of trypan blue nega-
tive (viable) cells.
Hexokinase assay
Hexokinase enzymatic activity was measured as pre-
viously described [15]. Briefly, cells were treated for
4 hour with DNP followed by radiation before
washed with PBS and lysed using the buffer containing
50 mM Tris-HCl (pH-8.0), 1.5 mM MgCl2, 150 mM
NaCl, 250mM sucrose along with protease inhibitor. The
cell lysate was incubated on ice for 30 min, followed by
centrifugation at 14,000 rpm at 4°C for 10 min. The pro-
tein estimation was done by BCA method. An aliquot of
20 μg protein from freshly lysed cell supernatant was
added to 1 ml of reaction buffer containing 100 mM
Tris-HCl, pH 8.0, 0.5 mM EDTA, 10 mM ATP, 10 mM
MgCl2, 2 mM glucose, 0.1 mM NADP, and 0.1 U/ml of
G6PD (Sigma). HK activity was determined by following
the G6P-dependent conversion of NADP to NADPH
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The values were subtracted with respective blanks and
the relative enzymatic activity is presented as absorption
at 340 nm.
ATP measurement
ATP was measured using ATP bioluminescent assay kit
(Sigma) following manufacturer’s protocol. Briefly, cells
were treated with MRMs followed by irradiation for
4 hour before washed and scraped in cold PBS and pel-
leted at 1000 rpm for 10 min. Further, cells were lysed in
350 μl of lysis buffer (4mM EDTA and 0.2% Triton
X-100). 100 μl of this lysate was loaded per well in
triplicates with 100 μl of ATP mix in a 96-well white
luminescence measuring plate. Luminescence of sam-
ples along with standards was read at 562 nm and
normalized with the protein concentration. ATP concen-
tration is depicted as ng/mg protein.
Measurement of mitochondrial content and membrane
potential
Cells were treated with MRMs followed with or without
irradiation for various time points. Once the incubation
time was completed, cells were washed with PBS and
stained for 30 minutes at 37°C in CO2 incubator with
either 100 nM mitotracker green or 100 nM DiOC6
(both from Molecular Probes, Invitrogen) in respective
wells. After staining, cells were trypsinized and equal
numbers of cells were transferred to 96 well fluores-
cence reading plate. The fluorescence was measured at
490 nm excitation and 516 nm emission for mitotracker
green and 484 nm excitation and 501 nm emission for
DiOC6 in quadruplicates using Molecular device
fluorescence plate reader. The fluorescence intensity
of mitotracker green is represented as relative mito-
chondrial content and the DiOC6 fluorescence inten-
sity is represented as relative mitochondrial membrane
potential.
Macro colony assay
Clonogenic survival was performed using post plating
method of macro colony assay. Cells were plated at a
density of 6,000 - 8,000 cells/cm2 in Petri dishes. 36 h
later, cells were washed with HBSS and treated with dif-
ferent MRMs (viz. 1 μM di-nitro phenol, DNP; 25 μg/ml
Photosan-3, PS3; 25 μM Methylene blue, MB) in HBSS
before irradiation. Following the radiation treatment,
cells were incubated for 4h at 37°C in HBSS in CO2 in-
cubator then washed twice with HBSS, trypsinized,
counted and plated in triplicates in 60 mm petri dish
at very low density (100 cells/dish) for control and
MRMs treatment alone and relatively high cell dens-
ity (500 cells/dish) for radiation (5 Gy) and MRMs
with radiation. These dishes were incubated in freshmedia at 37°C in a humidified CO2 (5%) incubator
for 7-10 days, depending on the cell line. Cultures
were terminated when macrocolonies were visible after
7-10 days, were fixed with 10% methanol in PBS and
stained with 1% crystal violet (dissolved in 7% metha-
nol in PBS). Colonies of at least 50 cells (5 to 6
doubling) were scored as survivors. Plating efficiency
was calculated as: PE = (No. of colonies counted/No
of cells plated) x 100. The surviving fraction was cal-
culated as: SF = PET /PEC. Where PET is the plating
efficiency of the treated group and PEC is the value
of the control.
Single cell gel electrophoresis (comet assay)
Neutral comet assay was performed as described earlier
[16,17]. For 0 hour time point (to obtain damage in-
duction) cells were exposed on ice and processed im-
mediately after exposure. Briefly, treated cells were
trypsinized and resuspended in the medium at re-
spective time points. An aliquot of 30,000-40,000
cells (~100 μl of medium) was mixed into a suspension of
0.75% (~500μl) warm low gelling (gelling temp = 17°C)
agarose (BDH Electran, England), and spread onto
microscopic slide (pre-coated with 0.1% agarose) kept
at 45°C. Slides were immediately transferred to a cool-
ing plate at 4°C, and kept for 5 min to allow the agar-
ose layer to gel along with the embedded cells.
Following this, the slides carrying agarose gel with em-
bedded cells were immersed in the SDS lysis buffer
[2.5% sodium dodecyl sulphate (SDS), 1% sodium sar-
cosinate and 25 mM ethylenediaminetetraacetic acid
(EDTA)] for 15 min at room temperature (25-28°C).
Slides were then washed in double distilled water for
5 min at 4°C, electrophoresed at 2 V/cm for 5 min,
and air-dried at 45°C. For analysis, the slides were
rehydrated by immersing in distilled water at room
temperature, and stained with 25 μg/ml propidium
iodide (PI) dye. Comet-like shape forms from the DNA
mass of each individual cell following these treatments,
the amount of DNA present in the tail directly cor-
responding with the amount of DNA breaks induced
by radiation treatment. The comets were randomly
selected (n = 50) and images were acquired at 200x
under BX60 fluorescence microscope (Olympus, Japan).
The comets were analyzed using OPTIMAS image ana-
lysis software (calibrated for analyzing comets) and the
tail moment was calculated from data generated by the
software.
Micronuclei assay
Cells were washed in PBS and fixed in carnoys fixa-
tive (3:1 V/V, Methanol: Acetic acid). Fixed cells
were dropped on the chilled glass slides. Air-dried
slides were stained with a DNA binding fluorochrome
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in citric acid [0.01 M], disodium phosphate [0.45 M] buf-
fer containing 0.05% Tween-20 detergent; pH 7.4 as
described earlier [6]. Slides were examined under fluores-
cence microscope using UV excitation filter. Cells con-
taining micronuclei were counted from 1000 cells as
described earlier [6,18].
Immuno-blot
Expression of key proteins involved in glucose catabol-
ism and DNA repair viz. glucose transporters GLUT-1,
GLUT-4, hexokinase-II (HK-II), PFK-1, HIF1α, Rad51,
Ku-70 and loading control β-Actin was determined in
control and treated cells by immunoblot analysis. Cells
were harvested at various time points (showed in figure)
and lysed in ice cold RIPA lysis buffer (Tris–HCl:
50mM, pH 7.4, NP-40: 1%, Na-deoxycholate: 0.25%,
NaCl: 150 mM, EDTA: 1 mM, PMSF: 2 mM, protease
inhibitor cocktail, Na3VO4: 1 mM, NaF: 1 mM). The
protein concentration in the lysates was measured using
BCA protein assay. Protein (40–50 μg) was resolved on
10–15% SDS–PAGE (depending on the molecular
weight) and electroblotted onto PVDF membrane
(MDI). The membrane was then incubated in 4%
skimmed milk for 1 h followed by primary antibody in-
cubation GLUT-1 (1:300), GLUT-4 (1:300), HK-II
(1:200), PFK-2 (1:200), Rad51 (1:200), Ku-70 (1:150)
from Santa Cruz Biotechnology, HIF1α (1:1000) from
Cell Signaling Tech. and β-Actin (1:5000) from BD
Biosciences for overnight. Membrane was washed and
incubated with the appropriate HRP conjugated second-
ary antibody for 1h. After washing, the blots were devel-
oped using ECL chemiluminescence detection reagent
(Biological industries, Israel). The signal was detected
by ECL, and band intensities for each individual pro-
tein were quantified by densitometry, corrected for
background staining, and normalized to the signal for
β-Actin.
Statistical analyses
All the experiments were performed in triplicates or
quadruplicates. Means and standard errors were com-
puted. Student’s t test was performed to determine
whether a significant difference exists between the
groups.
Results
Mitochondrial respiratory modifiers induces glycolysis
To mimic the high glycolytic phenotype of cancer cells,
we investigated the glycolysis stimulating potential of
few mitochondrial respiratory modifiers (MRMs) that
are known to stimulate glycolysis as a compensatory
mechanism [19]. At Treatment of exponentially growing
cells with non-toxic concentrations MRMs such asdi-nitrophenol (DNP), porphyrin derivatives (photosan;
PS3) and methylene blue (MB), which interfere with the
oxidative phosphorylation at different stages in the elec-
tron transport chain (ETC), was found to enhance the
glycolysis (glucose utilization and lactate production) sig-
nificantly (by approximately two folds) in both malignant
cell lines BMG-1 and OCT-1 (Figure 1A and B), similar
to our earlier results with KCN [11,12]. To test if com-
promised oxidative phosphorylation can induce the com-
pensatory increase in glycolysis in non-malignant cell
similar to malignant cells, we treated HEK cell line
(embryonic kidney) with MRMs under similar experi-
mental conditions. Interestingly, MRMs induced the glu-
cose uptake and lactate production in HEK cells also
(Figure 1C). Further, we observed that irradiation alone
also marginally increased glycolysis (Figure 1A, B and C)
as reported earlier [11], with further increase in presence
of MRMs (Figure 1A, B and C). It is pertinent to note
that compensatory increase in glycolysis due to inhibition
of oxidative phosphorylation appears to be not limited
only to malignant cells.
To unravel the contributing factors responsible for
MRM-induced enhancement in glycolysis, we examined
the level of glycolytic enzymes and glucose transporters
under similar experimental conditions. Interestingly, we
found approximately 2.5 fold increased level of GLUT-1,
while no significant change could be seen in GLUT-4
(Figure 1D). A 2 fold increase was also seen in the level
of hexokinase-II, one of the first two regulatory kinases
(HK-II and PFK-1) of glycolysis; however the level of
PFK-1 does not change appreciably (Figure 1D). DNP
treatment also showed increased level of hypoxia indu-
cible transcription factor, HIF1α which is known to in-
duce glycolysis. Further, the increase in hexokinase
expression also correlated with nearly two fold increase
in the total hexokinase activity (Figure 1E) induced by
DNP under these experimental conditions. Interestingly,
the hexokinase activity was increased further by nearly 4
fold in cells treated with both DNP and radiation. These
findings suggest that inhibition of mitochondrial respir-
ation stabilizes HIF1α which further induces glycolysis
by up-regulating the level of glucose transporters viz.
GLUT-1 and glucose phosphorylating enzyme HK-II to
ensure the increased flux and high retention of glucose
in the cytoplasm.
MRMs inhibit the process of electron transfer and
ATP generation from electron transport chain leading to
incomplete respiration and reduced ATP generation.
Therefore, we measured changes in ATP levels induced
by MRMs (Figure 2A), besides examining the mitochon-
drial status by analyzing the membrane potential and
mass (Figure 2B & C). Results (Figure 2) clearly show
that none of the three respiratory inhibitors caused any










































































































































































































Figure 1 Mitochondrial respiratory modifiers (MRMs; PS3, DNP & MB) induces glycolysis. Glucose consumption and lactate production observed
every hour till 4 hours of the drug treatment is presented as average per hour in BMG-1 (A), OCT-1 (B) and HEK293 (C) cells. (D) Protein expression
profile of glucose transporter, glycolytic enzymes and transcriptional regulator of glycolysis HIF1α is shown in BMG-1 cells. The data shows western
blots and their derived quantitative values from the densitometry. (E) Relative hexokinase enzymatic activity in un-irradiated and irradiated (5 Gy γ-rays)
BMG-1 cells is presented as absorbance at 340 nm obtained from coupled enzymatic assay. The concentration of different treatments used was as
follows, PS3, 25 μg/ml; DNP, 1 μM; MB, 25 μM. The data shown are the mean values (±1 SD) of nine observations from three independent experiments.
Statistical significance *p < 0.05.
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membrane potential was observed in cells co-treated
with MRMs and radiation (only at 4 hrs. time point;
Figure 2B & C). However, these changes were not sig-
nificant as compared to radiation alone. These findings
suggest that the significant compensatory increase in
glycolysis is sufficient to meet the energy requirements
in these cells. It also suggests that the effect of all the
MRMs on mitochondria is similar for compensatory
increase in glycolysis.
Transient elevation of glycolysis confers radio-resistance
in cells
To examine if transient induction of glycolysis leads to
radio-resistance, we irradiated (5 Gy; γ-Rays) the cells in
the presence of MRMs (that induce glycolysis) and then
analyzed the clonogenicity using macro-colony assay. In-
deed an increase in survival was evident in all the three
cell lines, which on an average was 1.71, 1.74 and 1.9
fold in BMG-1, OCT-1 and HEK293 respectively with
all the three MRMs as compared to radiation alone(Figure 3A, B and C). We further examined the effect of
DNP mediated enhanced glycolysis on the radiation dose
response curve in the cells and found that glycolysis
stimulated cells (DNP treated) showed radio-resistance
as reflected by an increase in D1 (dose of radiation to
bring down the survival fraction to 0.37) in all the three
cell lines (Figure 3D).
After establishing the “proof of concept” that elevation
of glycolysis for few hours post-irradiation leads to re-
sistance against radiation-induced cell death using more
than one inducers viz. DNP, PS3 and methylene blue, we
decided to investigate the mechanisms underlying this
resistance using a pharmacologically more suitable mol-
ecule like DNP, as PS3 and methylene blue are associ-
ated with photo-toxicity [8,20].
Inhibition of glycolysis reverses MRMs induced
radio-resistance
To confirm that MRMs induced radio-resistance is mainly
by induction of glycolysis, we inhibited the glycolysis




























































































































































Figure 2 MRMs did not induce differential changes in energy and
mitochondrial status in either un-irradiated or irradiated (5 Gy γ-rays)
BMG-1 cells. (A) Shows MRMs induced glycolysis compensate the
ATP production, equally in all the modifiers. (B) & (C) shows that the
effects of MRMs on mitochondrial mass and membrane potential are
also similar. The concentrations of different MRMs used were as
follows, PS3, 25 μg/ml; DNP, 1 μM; MB, 25 μM.
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hexokinase inhibitor) and fasentin (Glut-1 inhibitor) in
DNP treated BMG-1 cells before exposing to radiation.All these known inhibitors of glycolysis failed to enhance
the clonogenicity in DNP treated and irradiated cells as
compared to radiation alone (Figure 4A). To further sub-
stantiate that MRMs induced radio-resistance is facili-
tated by induced glycolysis and not due to metabolic
signaling associated with inhibition of mitochondrial res-
piration; we treated BMG-1 cells with non-toxic concen-
tration of antimycin A (5 μg/ml), which inhibits oxidative
phosphorylation but does not induce glycolysis [21]. Cells
treated with antimycin A before radiation exposure did
not show any increase in clonogenic survival (Figure 4B);
lending further support to the notion that MRMs in-
duced radio-resistance observed in cells is mediated by
transient stimulation of glycolysis.
Induced glycolysis facilitates DNA repair process
Since DNA damage is one of the major contributing fac-
tor for the loss of clonogenic survival at moderate levels
of absorbed radiation, we studied the effects of induced
glycolysis on the induction and repair of DNA damage
using single cell electrophoresis (Comet assay). We used
changes in tail moment (increase and decrease) as a par-
ameter to measure the damage induction and repair.
Figure 5A shows the tail moment in BMG-1 cells, un-
irradiated and immediately after irradiation. We ana-
lyzed the data using derived equations to determine the
percentage of damage removed and presented in Table 1.
Cells with stimulated glycolysis showed a faster kinetics
of repair and the extent of damage removal at the end of
30 minutes following irradiation. The extent of damage
removed was approximately 2.06 (93% / 45%) fold higher
as compared to the un-stimulated cells (Figure 5B). Ana-
lysis of the repair kinetics showed that almost all damage
repaired under conditions of stimulated glycolysis was han-
dled by the fast component of repair (~93%) as compared
to the un-stimulated cells (~45%). These results suggest
that a higher rate as well as the extent of damage removal
under conditions of enhanced glycolysis is one of the im-
portant contributing factors for enhanced resistance.
Because, radiation predominantly causes mitotic catas-
trophe (an event in which a cell is destroyed during
mitosis) linked death at moderate doses [22], we investi-
gated radiation induced cytogenetic damage, which is in-
volved in mitotic catastrophe. Cytogenetic damage was
assessed by counting cells with micronucleus, which
arises from unrepaired/mis-repaired DNA double strand
breaks (DSBs) following irradiation and correlates with
changes in survival [23]. The kinetics of micronuclei ex-
pression followed until 72 h post-irradiation clearly
showed a significant decrease in the fraction of cells with
micronuclei in glycolysis stimulated BMG-1, OCT-1 and
HEK293 cells at all time points (Figure 5C) suggesting
reduced residual DNA damage, in line with the en-



































































































































Figure 3 MRMs induces radio-resistance. Enhanced radio-resistance (clonogenic survival; macro-colony assay) observed due to MRMs (PS3, DNP
and MB) induced glycolysis in BMG-1 (A), OCT-1 (B) and HEK293 (C). The figure (D) represents the dose response curve of BMG-1, OCT-1 and
HEK293 cells against radiation in DNP and vehicle treated cells. The concentrations of MRMs used were as follows, PS3, 25 μg/ml; DNP, 1 μM; MB,
25 μM. After treatment cells were incubated for 4 hours in liquid holding before plating for macro colony formation. Surviving fraction of un-irradiated
and irradiated samples was calculated by considering the plating efficiency of un-irradiated control as 1. The data shown are the mean values (±1 SD)
of nine observations from three independent experiments. Statistical significance *p < 0.05.
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DNA repair
DSBs are particularly deleterious to cells and its inef-
ficient repair can lead to cell death. DSBs in the
mammalian genome are repaired through homologous
recombination (HR) and non-homologous end joining
(NHEJ) repair pathways. Rad51 is a critical component of
the HR pathway whereas; Ku-70 and Ku-80 are critical
component of NHEJ pathway [24]. To examine if a par-
ticular DSB repair pathway is facilitated under the condi-
tions of induced glycolysis, we examined the status of
DSB repair initiating proteins, Rad51 and Ku-70 involved
in HR and NHEJ repair pathways, respectively. Western
blot analysis carried out in BMG-1 cells showed that the
level of Rad51 protein increased approximately 1.5 fold
at 4h following irradiation (5 Gy; Figure 6). However, in
DNP treated cells, an early 2 fold increase was noted in
the level of Rad51 at 0.5 h after irradiation (Figure 6),
suggesting a rapid induction of repair and faster removal
of DSB leading to lesser residual DNA damage in glycoly-
sis stimulated cells. Similar results were obtained for time
dependent changes in Ku-70 levels, which was also found
to be up-regulated by 2 folds, 0.5 hr after irradiation, in
DNP treated cells (Figure 6A). Although, increase in
Rad51 level correlates with the faster repair kinetics ob-
served here, increase in the level of Rad51 following ir-
radiation are at variance with earlier observations [25,26].
These observations are in line with our observations of afaster rate of DNA break rejoining (Figure 5B), wherein
the damage (tail moment) returned close to the basal
level within 0.5 h following irradiation in glycolysis
stimulated cells (Figure 5B). Inhibition of glycolysis using
2-DG in DNP stimulated cells did not show appreciable
increase in the level of these repair proteins Rad51
and Ku70, lending support to the proposition that
stimulation of glycolysis enhances the kinetics of DNA
repair by increasing the expression of repair proteins
Rad51 and Ku70. These results suggest that both HR
and NHEJ pathways of DNA repair are operationally
efficient following stimulation of glycolysis, thereby
leading to a faster damage removal and enhanced sur-
vival. Taken together, these observations suggest that
DNP induced transient elevation of glycolysis results
in activation of both HR and NHEJ pathway to facili-
tate the DNA repair thereby making the cells relatively
more resistant.
Discussion
Irradiation of cells causes macromolecular damage (viz
DNA, protein etc) stimulating multiple signaling path-
ways viz DNA repair, cell cycle check points, apoptosis
and senescence that collectively determine the fate
of cells [22]. It is well established that at moderate
absorbed doses of low LET radiation (like gamma rays
and X-rays), the main contributing factor responsible for
























































Figure 4 Glycolytic inhibitors reverse MRMs induced radio-resistance.
Inhibition of glycolysis by 2-DG (5 mM), 3-BP (5 μM) and fasentin
(25 μM) followed by DNP treatment before irradiation (5 Gy) reverses
glycolysis induced radio-resistance in BMG-1 cells (A). Both DNP and
inhibitors of glycolysis/ glucose transporter were added simultaneously
before irradiation. Inhibition of mitochondrial respiration without
up-regulating glycolysis (using 5 μg/ ml Antimycin A) does not
confer radio-resistance in BMG-1 cells (B). The data shown are the
mean values (±1 SD) of nine observations from three independent
experiments. Differences were statistically significant (*p < 0.05).
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DNA damage [22,27]. Incomplete repair and/or mis-
repair of DNA strand breaks results in chromosomal
damage that can be observed as various chromosomal
aberrations in the metaphase of the irradiated popula-
tion and as micronuclei in the daughter cells [27],
although mitotic spindle dysfunction and other distur-
bances also lead to micronuclei formation and related
nuclear damage [28]. Therefore, alterations in the DNA
repair processes that are operative for few hours follow-
ing irradiation are expected to influence the cell sur-
vival as well as the level of cytogenetic damage. In the
present study, we observed an increase in the clono-
genic survival following transient stimulation of glycoly-
sis (Figure 3) that correlated with the decrease in the
level of micronuclei expression (Figure 5C) suggesting a
reduction in the residual DNA damage under these
conditions. While stimulation of glycolysis did not sig-
nificantly alter the level of induction of DNA damage(Figure 5A), the rate of DNA strand break rejoining as
well as the extent of damage removal were clearly
higher that resulted in a decrease in the residual DNA
damage at the end of 30 minutes after irradiation
(Figure 5B).
It will be interesting to see whether the mechanisms
underlying radio-resistance seen in cancer cells, where a
stable phenotype with enhanced glycolysis gradually de-
velops during tumorigenesis will be identical to the tran-
sient stimulation of glycolysis observed here. In this
respect, it is pertinent to note that inhibition of mito-
chondrial respiration [29] that leads to enhanced gly-
colysis (as seen here; Figure 1) often results in the
stimulation of HIF1α expression of many genes in the
glycolytic pathway and up-regulated in malignantly
transformed cells and tumors [30,31]. Stimulation of gly-
colysis seen as a compensatory mechanism following a
fall in the mitochondrial ATP production induced by re-
spiratory inhibitors has been suggested to be due to the
activation of AMP kinase triggered by an increase in the
AMP level (and AMP/ATP ratio) due to ATP breakdown
[29]. Some recent evidences suggest that inhibition of
mitochondrial respiration leads to accumulation of
glycolytic end products like pyruvate and lactate which
could dramatically increase HIF1α accumulation in can-
cer cells by inhibiting the prolyl hydroxylase enzyme ac-
tivity. Moreover, other mediators like the expression of
TKTL1 (Transketolase-like 1, an enzyme of pentose
phosphate pathway) in head and neck carcinomas and
gliomas leads to metabolic switch by stabilizing HIF1α
for improving energy yield from glucose via glycolysis
and enhancing antioxidant defence against ROS via pen-
tose phosphate pathway [32,33]. In this respect it is per-
tinent to note that the increase in the protein levels of
regulators of glycolysis stimulated by DNP in BMG-1
cells viz. Glut-1 and HK-II observed here (Figure 1D)
are all regulated by HIF1α [9,27]. Therefore, radio-
resistance following DNP induced transient elevation in
glycolysis appears to partly involve similar mechanisms
that are reported as activators of glycolysis in cancer
cells generally associated with resistance to radiation and
other drugs. Further, sensitization of BMG-1 cells to ra-
diation in the presence of Antimycin A (Figure 4B),
which inhibits mitochondrial respiration without com-
pensatory increase in glycolysis and the glycolytic inhibi-
tor 2-DG strongly suggests that MRMs (DNP, PS3 and
MB) induced radio-resistance in cells is mainly due to
increase in glycolysis and not because of inhibition of
mitochondrial respiration.
DNA double strand breaks, the most lethal lesions
widely considered to be responsible for radiation-
induced cell death are repaired by both homologous
recombination (HR) and non-homologous end joining
(NHEJ) in a proliferating mammalian cell population.



















































































































Figure 5 DNP induced glycolysis facilitates repair of radiation-induced DNA double strand breaks. Effects of DNP (1 μM) induced glycolysis on
the induction (A) and kinetics of repair (B) of radiation (5 Gy) induced DNA damage assayed using single-cell gel electrophoresis in BMG-1 cells.
(C) Reduction in the radiation induced cytogenetic damage (micronuclei expression) observed in glycolysis stimulated (DNP treated) BMG-1,
OCT-1 and HEK293 cells. The data shown are the mean values (±1 SD) of three independent experiments. Differences were statistically significant
(*p < 0.05).
Bhatt et al. BMC Cancer  (2015) 15:335 Page 9 of 12Rad51 is a critical component of DNA DSB repair path-
way [34], which is widely reported to redistribute within
the nucleus following DNA damage suggesting the for-
mation of repair foci involving this recombinase
[25,26,35], although radiation induced elevated level of
this protein enhances radio-resistance has also been re-
ported [35]. Rapid increase in the level of Rad51 protein
at 30 minutes following irradiation in glycolysis stimu-
lated (DNP treated) cells observed here (Figure 6) is
similar to the observations in the radio-resistant spher-
oids of DU145 carcinoma cell line [36]; which also inter-
estingly has a significant level of HIF1α with elevated
glycolysis and increased resistance to radiation [37]. In-
creased level of Rad51 following irradiation seen here,
particularly in DNP treated cells is at variance withearlier reports [25,26,35] and may arise due to many rea-
sons viz. proteasomal degradation, altered metabolic sta-
tus of the cells [36,38] or changes in the interactions
with other members of the repair complex thereby alter-
ing the immune reactivity, which needs further investi-
gations. A profound increase in the level of Ku-70
(Figure 6) in DNP treated cells also facilitates a faster re-
pair by NHEJ conferring resistance against radiation in
high glycolytic cells. Increased level of Ku-70 has been
reported to increase cellular tolerance against ischemic
stress [39] and adaptation to ischemia provides hypoxia
mediated in-vivo tumor radio-resistance [40]. Our re-
sults also suggest that increased Ku-70 level may facili-
tate NHEJ pathway of DSB repair in high glycolytic
cells leading to reduced micronuclei and increased cell
Table 1 Table represents the DNA damage and repair
parameters like damage induction and damage removal
after 30 minutes between treated and untreated
irradiated groups
Parameters Formula/derivation Result
Damage Induction, DI Tail moment, TM at 0 min. – TM
in un-irradiated sample
DI without DNP, DIc 21.2 – 12.3 (a.u.) 8.9
(values obtained from Figure 5A)
DI for DNP treated, DId 19.6 – 12.0 (a.u.) 7.6
(values obtained from Figure 5A)
% Damage removed at
30 min., DR30min.
[(TM0min. – TM30min)/DI] x 100
DR without DNP,
DRc30min
[(21.2 – 17.2)/8.9] x 100 = [0.45] x 100 45%
(values obtained from Figure 5A & B)
DI for DNP treated,
DRd30min
[(19.6 – 12.5)/7.6] x 100 = [0.93] x 100 93%
(values obtained from Figure 5A & B)
Fold change in damage
removed at 30 min.
DRd30min/ DRc30min
93/45 2.06
The values were obtained from Figure 5 A & B and applied in the derived
formulas to obtain the final fold change of damage removed.
Bhatt et al. BMC Cancer  (2015) 15:335 Page 10 of 12survival against radiation. Some recent evidences suggest
that DNA damage induced by adriamycin enhances
the TIGAR and TKTL1 expression and knocking
down the TKTL1 or WRN complex both leads to re-
duced glycolytic metabolism and accumulation of
DNA damage in cancer cells [33,41]. Although these
observations strongly suggest enhanced repair of
radiation-induced DNA DSBs by stimulated glycolysis,1.0 1.0 1.5 2.1 2.4 2
1.0 1.1 1.6 1.3 2.6 1
0.5       4
hrs. after IR
Control DNP
0.5       
hrs. after
Figure 6 Time dependent changes in the levels of DNA repair proteins (Ra
effects of DNP (1 μM) and DNP > 2-DG (5 mM) in BMG-1 cells. Numbers sh
normalized with respective β-actin using densitometry on Imagequant 5.2
control of each group.underlying mechanisms responsible for this can only be
unraveled using studies with DNA repair deficient and
efficient cell systems following the stimulation of glycoly-
sis. Pending this insight to be unraveled, results of the
present studies lend support to our hypothesis that
enhanced glycolysis is a favorable metabolic change that
facilitates DNA repair, which appears to be partly respon-
sible for radio-resistance, which is often observed in can-
cer cells.
The transient increase in glycolysis conferring resist-
ance against radiation-induced cell death in normal
HEK293 cells (clonogenic survival; Figure 3C) has im-
portant implications in radiation countermeasure, as
pharmacological agents that stimulate glycolysis at the
systemic level may act as radio-protective agents. Indeed,
administration of low amounts of, DNP used in this
study for stimulating glycolysis has been shown to be
safe for humans/canine [42]. Facilitated DNA repair
leading to reduced cytogenetic damage and mitotic
linked cell death along with upregulated level of HK-II
and Ku-70 which are generally elevated with the increase
in glycolysis is known to inhibit intrinsic pathway of
apoptosis [43] and therefore can protect both the
hematopoietic and Gastro Intestinal system.
Conclusion
In the present study, we show that transient induction of
glycolysis by respiratory inhibitors gives rise to radio-
resistance by activating both the NHEJ and HR DNA re-
pair pathways, thereby reducing residual DNA damage
and cytogenetic damage linked mitotic death. Further
understanding of the mechanisms underlying glycolysis
induced facilitated DNA repair and radio-resistance may.2 1.2 1.6 1.0







0.5       4
hrs. after IR
d51 and Ku-70) observed following irradiation (5 Gy) showing the
own below the bands in the western blots represent the values
program and represents the fold change relative to unirradiated
Bhatt et al. BMC Cancer  (2015) 15:335 Page 11 of 12help in unraveling critical molecular targets responsible
for resistance and facilitate the design and/or identifica-
tion of molecules/agents that specifically overcome
resistance linked to enhanced glycolysis, thereby enhan-
cing the efficacy of radio- and chemotherapies.
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